cash flow reconciliationreview2020-12-31
Operating, investing and financing flows differ from the reported change in cash by 75051000, beyond tolerance 6588070.00.
Revenue
$3.31B
Fiscal year ended 2025-12-31Operating income
Unavailable
Fiscal year ended 2025-12-31Free cash flow
-$439.91M
Fiscal year ended 2025-12-31Acadia Healthcare Company, Inc. (ACHC) reported revenue of $3.31B and net income of -$1.10B for the fiscal year ended 2025-12-31. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from Acadia Healthcare Company, Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Services-Specialty Outpatient Facilities, NEC.
Income
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.31B | $3.15B | $2.93B | $2.61B | $2.31B | $2.09B | $2.01B | $1.90B | $2.84B | $2.81B |
| Cost of revenue | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Gross profit | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Operating income | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | $585.88M | $593.58M | $604.36M | $608.59M |
| Net income | -$1.10B | $255.61M | -$21.67M | $273.14M | $190.64M | -$672.13M | $108.92M | -$175.75M | $199.84M | $6.14M |
| Research & development | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Weighted-average diluted shares | shares 90.70M | shares 92.06M | shares 90.95M | shares 91.56M | shares 90.79M | shares 88.60M | shares 87.82M | shares 87.42M | shares 87.06M | shares 85.97M |
| Pretax income | -$1.07B | $341.88M | -$25.36M | $374.14M | $275.76M | $183.80M | $78.40M | $67.40M | $236.80M | $32.96M |
| Income tax expense | $25.98M | $77.40M | -$9.70M | $94.11M | $67.56M | $40.61M | $25.08M | $9.91M | $37.21M | $28.78M |
| Diluted EPS | $-12.16 | $2.78 | $-0.24 | $2.98 | $2.10 | $-7.59 | $1.24 | $-2.01 | $2.30 | $0.07 |
| Selling, general & administrative | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| General & administrative | $177.60M | $156.80M | $153.30M | $124.30M | $108.20M | $97.80M | $90.40M | $86.60M | $76.40M | $86.80M |
| Selling & marketing | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Balance
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $133.24M | $76.30M | $100.07M | $97.65M | $133.81M | $378.70M | $99.54M | $50.51M | $67.29M | $57.06M |
| Total assets | $5.53B | $5.96B | $5.36B | $4.99B | $4.77B | $6.50B | $6.88B | $6.17B | $6.42B | $6.02B |
| Current assets | $814.14M | $577.49M | $596.00M | $506.12M | $495.03M | $2.52B | $542.21M | $450.42M | $471.55M | $427.93M |
| Total liabilities | $3.39B | $2.77B | $2.47B | $2.09B | $2.19B | $4.54B | $4.34B | $3.81B | $3.83B | $3.84B |
| Current liabilities | $525.19M | $577.92M | $885.78M | $388.33M | $404.86M | $1.31B | $463.58M | $416.38M | $377.39M | $342.86M |
| Total equity incl. NCI | $1.95B | $3.07B | $2.78B | $2.81B | $2.52B | $1.90B | $2.51B | $2.33B | $2.57B | $2.17B |
| Temporary (mezzanine) equity | $191.59M | $117.12M | $105.69M | $88.26M | $65.39M | $55.32M | $33.15M | $28.81M | $22.42M | $17.75M |
| Inventory | $5.69M | $5.65M | $5.30M | $5.09M | $4.79M | $4.85M | $4.08M | $5.06M | $4.79M | $4.63M |
| Accounts receivable | $440.60M | $365.34M | $361.45M | $322.44M | $281.33M | $273.55M | $288.86M | $318.09M | $296.92M | $263.33M |
| Goodwill | $1.30B | $2.26B | $2.23B | $2.22B | $2.20B | $2.11B | $2.09B | $2.04B | $2.75B | $2.68B |
| Long-term debt | $2.47B | $1.88B | $1.34B | $1.36B | $1.48B | $2.97B | $3.11B | $3.16B | $3.21B | $3.25B |
| Accounts payable | $150.40M | $232.70M | $156.13M | $104.72M | $98.58M | $87.82M | $90.26M | $117.74M | $102.30M | $80.03M |
Cash flow
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $131.90M | $129.69M | $462.34M | $380.57M | $374.48M | $658.81M | $332.90M | $414.08M | $399.58M | $361.48M |
| Capital expenditures | $571.81M | $690.38M | $424.13M | $296.15M | $244.81M | $224.96M | $232.68M | $253.19M | $274.18M | $307.47M |
| Investing cash flow | -$556.21M | -$736.48M | -$397.22M | -$305.83M | $1.01B | -$281.84M | -$201.14M | -$360.96M | -$336.53M | -$660.36M |
| Financing cash flow | $481.25M | $583.02M | -$62.70M | -$110.90M | -$1.64B | -$51.50M | -$61.63M | -$67.33M | -$60.07M | $358.84M |
| Net change in cash | $56.94M | -$23.77M | $2.42M | -$36.16M | -$244.88M | $254.50M | $49.02M | -$37.10M | $10.23M | $45.85M |
| Stock-based compensation | $31.71M | $37.11M | $32.29M | $29.64M | $37.53M | $22.50M | $17.31M | $22.00M | $23.47M | $28.34M |
| Common dividends paid | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Common share repurchases | $50.03M | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Depreciation & amortization | $189.25M | $149.60M | $132.35M | $117.77M | $106.72M | $95.26M | $87.92M | $80.34M | $143.01M | $135.10M |
Derived
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Free cash flow | -$439.91M | -$560.69M | $38.21M | $84.42M | $129.67M | $433.84M | $100.22M | $160.89M | $125.40M | $54.01M |
| Gross margin | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Operating margin | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | 21.3% | 21.7% |
| FCF margin | -13.3% | -17.8% | 1.3% | 3.2% | 5.6% | 20.8% | 5.0% | 8.4% | 4.4% | 1.9% |
| SBC / revenue | 1.0% | 1.2% | 1.1% | 1.1% | 1.6% | 1.1% | 0.9% | 1.2% | 0.8% | 1.0% |
| Current ratio | 1.55x | 1.00x | 0.67x | 1.30x | 1.22x | 1.93x | 1.17x | 1.08x | 1.25x | 1.25x |
| Revenue YoY growth | 5.0% | 7.7% | 12.2% | 12.8% | 10.7% | 4.1% | 5.4% | -32.8% | 0.9% | Unavailable |
| Net margin | -33.3% | 8.1% | -0.7% | 10.5% | 8.2% | -32.2% | 5.4% | -9.2% | 7.0% | 0.2% |
| R&D / revenue | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| CapEx / revenue | 17.3% | 21.9% | 14.5% | 11.3% | 10.6% | 10.8% | 11.6% | 13.3% | 9.7% | 10.9% |
| Long-term debt / equity | 1.27x | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Effective tax rate | Unavailable | 22.6% | Unavailable | 25.2% | 24.5% | 22.1% | 32.0% | 14.7% | 15.7% | 87.3% |
Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open ACHC in the interactive workspace to inspect any figure back to its filing.
Source filings
10-Q · Filed 2026-04-30View SEC filing
10-K · Filed 2026-02-27View SEC filing
10-Q · Filed 2025-11-05View SEC filing
10-Q · Filed 2025-08-05View SEC filing
10-Q · Filed 2025-05-12View SEC filing
10-K · Filed 2025-02-27View SEC filing
Reconciliation checks needing review
3 periods on this page do not reconcile under this site’s normalization. Read that as a limitation here before an observation about the company: the figures are the filer’s own, the filings linked above are authoritative, and a difference usually means the concepts this site selected do not match how this filer presents its statements. Nothing is adjusted to make a check pass.
cash flow reconciliationreview2019-12-31
Operating, investing and financing flows differ from the reported change in cash by 24657000, beyond tolerance 3329040.00.
cash flow reconciliationreview2018-12-31
Operating, investing and financing flows differ from the reported change in cash by 20318000, beyond tolerance 4140800.00.